[Isolation and quantification of a 17-epi-dammarane triterpenoid rhuslactone from roots of Rhus chinensis and its preventive effects on coronary heart disease and thrombosis in zebrafish].

Scientists isolated and identified rhuslactone, a rare compound from Rhus chinensis. It can be quantified and showed potential preventive effects against coronary heart disease and thrombosis. It also challenges previous assumptions about the stereochemistry of similar compounds.

Ruan LJ et al (2023).

Zhongguo Zhong Yao Za Zhi.

DOI:

10.19540/j.cnki.cjcmm.20221227.201

PubMed:

37005844

New Approaches on the Anti-Inflammatory and Cardioprotective Properties of Taraxacum officinale Tincture.

Epure A et al (2023).

Pharmaceuticals (Basel).

DOI:

10.3390/ph16030358

PubMed:

36986458

Beans comsumption can contribute to the prevention of cardiovascular disease.

Vieira NM et al (2023).

Clin Nutr ESPEN.

DOI:

10.1016/j.clnesp.2023.01.007

PubMed:

36963901

Taraxacum officinale-derived exosome-like nanovesicles modulate gut metabolites to prevent intermittent hypoxia-induced hypertension.

Zhang X et al (2023).

Biomed Pharmacother.

DOI:

10.1016/j.biopha.2023.114572

PubMed:

36963360

GLUT4 mediates the protective function of gastrodin against pressure overload-induced cardiac hypertrophy.

Zhang M et al (2023).

Biomed Pharmacother.

DOI:

10.1016/j.biopha.2023.114324

PubMed:

36958192

Stachydrine, a potential drug for the treatment of cardiovascular system and central nervous system diseases.

Researchers have conducted a review on the traditional Chinese herb, Leonurus japonicus Houtt, and its primary component, stachydrine, which has been shown to have biological activities such as anti-inflammatory, antioxidant, anti-coagulant, anti-apoptotic, vasodilator, and angiogenic promoter. The herb is commonly used in China for gynecological and blood-related disorders, and has unique advantages in the prevention and treatment of cardiovascular disease (CVD). The study aims to provide a scientific basis for the development of new CVD drug formulations.

Liao L et al (2023).

Biomed Pharmacother.

DOI:

10.1016/j.biopha.2023.114489

PubMed:

36940619

Ginkgolide A targets forkhead box O1 to protect against lipopolysaccharide-induced septic cardiomyopathy.

Wang L et al (2023).

Phytother Res.

DOI:

10.1002/ptr.7802

PubMed:

36932920

Baicalin inhibits pressure overload-induced cardiac hypertrophy by regulating the SIRT3-dependent signaling pathway.

Cai Y et al (2023).

Phytomedicine.

DOI:

10.1016/j.phymed.2023.154747

PubMed:

36931095